ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Evogene Ltd

Evogene Ltd (EVGN)

1,35
0,06
(4,65%)
Geschlossen 22 Dezember 10:00PM
1,35
0,00
(0,00%)
Nach Börsenschluss: 1:00AM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
1,35
Gebot
1,21
Fragen
1,92
Volumen
129.007
1,30 Tagesbereich 1,44
1,20 52-Wochen-Bereich 10,40
Marktkapitalisierung
Handelsende
1,29
Handelsbeginn
1,30
Letzte Trade
50
@
1.35
Letzter Handelszeitpunkt
Finanzvolumen
US$ 178.940
VWAP
1,3871
Durchschnittliches Volumen (3 Mio.)
301.360
Ausgegebene Aktien
5.079.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,29
Gewinn pro Aktie (EPS)
-4,7
Erlöse
5,64M
Nettogewinn
-23,88M

Über Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB plat... Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment. Mehr anzeigen

Sektor
Agricultural Chemicals
Branche
Biological Pds,ex Diagnstics
Website
Hauptsitz
Rehovot, Center, Isr
Gegründet
2011
Evogene Ltd is listed in the Agricultural Chemicals sector of the NASDAQ with ticker EVGN. The last closing price for Evogene was US$1,29. Over the last year, Evogene shares have traded in a share price range of US$ 1,20 to US$ 10,40.

Evogene currently has 5.079.000 shares in issue. The market capitalisation of Evogene is US$6,55 million. Evogene has a price to earnings ratio (PE ratio) of -0.29.

EVGN Neueste Nachrichten

Evogene Reports Third Quarter 2024 Financial Results

Evogene Reports Third Quarter 2024 Financial Results PR Newswire REHOVOT, Israel, Nov. 21, 2024 Conference call and webcast: today, November 21, 2024, 9:00 am ET Financial Highlights: In the...

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results PR Newswire REHOVOT, Israel, Nov. 19, 2024...

Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials

Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials PR Newswire REHOVOT, Israel, Nov. 12, 2024 Lavie Bio intends to commence Yalos®...

Evogene Schedules Third Quarter 2024 Financial Results Release

Evogene Schedules Third Quarter 2024 Financial Results Release PR Newswire REHOVOT, Israel, Nov. 7, 2024 Zoom conference call scheduled for November 21, 2024, 9:00 AM ET REHOVOT, Israel, Nov. 7...

Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design

Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design PR Newswire REHOVOT, Israel, Oct. 31, 2024 The collaboration has the...

Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya

Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya PR Newswire REHOVOT, Israel, Oct...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.053.846153846151.31.371.2437791.30603707CS
4-0.24-15.09433962261.591.731.2536631.47116208CS
12-1.15-462.53.321.23013602.20159651CS
26-5.051-78.90954538356.4017.191.21787432.93106277CS
52-6.65-83.125810.41.21610035.2965934CS
156-16.95-92.622950819718.3191.21741398.85624827CS
260-11.95-89.849624060213.3102.3861.235130433.75314073CS

EVGN - Frequently Asked Questions (FAQ)

What is the current Evogene share price?
The current share price of Evogene is US$ 1,35
How many Evogene shares are in issue?
Evogene has 5.079.000 shares in issue
What is the market cap of Evogene?
The market capitalisation of Evogene is USD 6,55M
What is the 1 year trading range for Evogene share price?
Evogene has traded in the range of US$ 1,20 to US$ 10,40 during the past year
What is the PE ratio of Evogene?
The price to earnings ratio of Evogene is -0,29
What is the cash to sales ratio of Evogene?
The cash to sales ratio of Evogene is 1,22
What is the reporting currency for Evogene?
Evogene reports financial results in USD
What is the latest annual turnover for Evogene?
The latest annual turnover of Evogene is USD 5,64M
What is the latest annual profit for Evogene?
The latest annual profit of Evogene is USD -23,88M
What is the registered address of Evogene?
The registered address for Evogene is 13 GAD FEINSTEIN STREET, PARK REHOVOT, P.O.B 4173 NESS ZIONA, REHOVOT, CENTER, 7414002
What is the Evogene website address?
The website address for Evogene is www.evogene.com
Which industry sector does Evogene operate in?
Evogene operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,32M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
305,1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
292,16M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
287,21M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
277,63M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock